dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study. (PubMed, Acta Ophthalmol) - Jul 19, 2022 - "Topical OCS-01 was significantly more effective than vehicle in improving central macular thickness in patients with DME. Visual improvement was better in eyes with lower baseline vision." 
Journal • Diabetic Macular Edema • Ophthalmology
http://www.ncbi.nlm.nih.gov/pubmed/35848336
 
Jul 19, 2022
 
Prev Next